Biological therapy in the inflammatory disorders of the upper airway: the endotype-driven treatment of chronic rhinosinusitis

被引：3

作者：

Hirschberg, Andor ^{[1
,2
]}

机构：

[1] Eszak Kozep Budai Ctr, Uj Szent Janos Korhaz & Szakrendelo, Ful Orr Gege Fej Nyak & Szajsebeszeti Osztaly, Budapest, Hungary

[2] Dios Arok 1-3, H-1125 Budapest, Hungary

来源：

ORVOSI HETILAP | 2023年 / 164卷 / 18期

关键词：

biologics; chronic rhinosinusitis; nasal polyp; NASAL POLYPOSIS; MEPOLIZUMAB;

D O I：

10.1556/650.2023.32792

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with difficult-to-treat chronic bilateral rhinosinusitis with nasal polyps - a type 2 inflammatory endotype - who are resistant to conventional medical and surgical therapy exhibit prolonged and not controlled symptoms. Quality of life, daily activities and sleeping are severely affected. Symptomatic, etiopathologic, surgical and general antiinflammatory (systemic steroid) therapeutic options of the past decades have not been sufficient enough in the treatment of refractory chronic rhinosinusitis. The new therapy with humanized monoclonal antibodies directed against the most relevant mediators and effector cells resulted in outstanding impovements in this field. Other type 2 manifestations may also be effectively treated at the same time, which improves the quality of life and is considered cost-effective as well. The author summarizes the actual etiopathogenic and clinical implications, the approved and available biologics, the related evidences and the preliminary clinical experiences.

引用

页码：694 / 701

页数：8

共 13 条

[1] Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial [J].

Bachert, Claus ;

Han, Joseph K. ;

Desrosiers, Martin Y. ;

Gevaert, Philippe ;

Heffler, Enrico ;

Hopkins, Claire ;

Tversky, Jody R. ;

Barker, Peter ;

Cohen, David ;

Emson, Claire ;

Martin, Ubaldo J. ;

Shih, Vivian H. ;

Necander, Sofia ;

Kreindler, James L. ;

Jison, Maria ;

Werkstrom, Viktoria .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (04) :1309-+

[2] Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials [J].

Bachert, Claus ;

Han, Joseph K. ;

Desrosiers, Martin ;

Hellings, Peter W. ;

Amin, Nikhil ;

Lee, Stella E. ;

Mullol, Joaquim ;

Greos, Leon S. ;

Bosso, John V. ;

Laidlaw, Tanya M. ;

Cervin, Anders U. ;

Maspero, Jorge F. ;

Hopkins, Claire ;

Olze, Heidi ;

Canonica, G. Walter ;

Paggiaro, Pierluigi ;

Cho, Seong H. ;

Fokkens, Wytske J. ;

Fujieda, Shigeharu ;

Zhang, Mei ;

Lu, Xin ;

Fan, Chunpeng ;

Draikiwicz, Steven ;

Kamat, Siddhesh A. ;

Khan, Asif ;

Pirozzi, Gianluca ;

Patel, Naimish ;

Graham, Neil M. H. ;

Ruddy, Marcella ;

Staudinger, Heribert ;

Weinreich, David ;

Stahl, Neil ;

Yancopoulos, George D. ;

Mannent, Leda P. .

LANCET, 2019, 394 (10209) :1638-1650

[3] Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis A Randomized Clinical Trial [J].

Bachert, Claus ;

Mannent, Leda ;

Naclerio, Robert M. ;

Mullol, Joaquim ;

Ferguson, Berrylin J. ;

Gevaert, Philippe ;

Hellings, Peter ;

Jiao, Lixia ;

Wang, Lin ;

Evans, Robert R. ;

Pirozzi, Gianluca ;

Graham, Neil M. ;

Swanson, Brian ;

Hamilton, Jennifer D. ;

Radin, Allen ;

Gandhi, Namita A. ;

Stahl, Neil ;

Yancopoulos, George D. ;

Sutherland, E. Rand .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (05) :469-479

[4] Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial [J].

Bachert, Claus ;

Sousa, Ana R. ;

Lund, Valerie J. ;

Scadding, Glenis K. ;

Gevaert, Philippe ;

Nasser, Shuaib ;

Durham, Stephen R. ;

Cornet, Marjolein E. ;

Kariyawasam, Harsha H. ;

Gilbert, Jane ;

Austin, Daren ;

Maxwell, Aoife C. ;

Marshall, Richard P. ;

Fokkens, Wytske J. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (04) :1024-+

[5] European Position Paper on Rhinosinusitis and Nasal Polyps 2020 [J].

Fokkens, Wytske J. ;

Lund, Valerie J. ;

Hopkins, Claire ;

Hellings, Peter W. ;

Kern, Robert ;

Reitsma, Sietze ;

Toppila-Salmi, Sanna ;

Bernal-Sprekelsen, Manuel ;

Mullol, Joaquim ;

Alobid, Isam ;

Anselmo-Lima, Wilma Terezinha ;

Bachert, Claus ;

Baroody, Fuad ;

von Buchwald, Christian ;

Cervin, Anders ;

Cohen, Noam ;

Constantinidis, Jannis ;

De Gabory, Ludovic ;

Desrosiers, Martin ;

Diamant, Zuzana ;

Douglas, Richard G. ;

Gevaert, Philippe H. ;

Hafner, Anita ;

Harvey, Richard J. ;

Joos, Guy F. ;

Kalogjera, Livije ;

Knill, Andrew ;

Kocks, Janwillem H. ;

Landis, Basile N. ;

Limpens, Jacqueline ;

Lebeer, Sarah ;

Lourenco, Olga ;

Matricardi, Paolo M. ;

Meco, Cem ;

O'Mahony, Liam ;

Philpott, Carl M. ;

Ryan, Dermot ;

Schlosser, Rodney ;

Senior, Brent ;

Smith, Timothy L. ;

Teeling, Thijs ;

Tomazic, Peter Valentin ;

Wang, De Yun ;

Wang, Dehui ;

Zhang, Luo ;

Agius, Adrian M. ;

Ahlstrom-Emanuelsson, Cecilia ;

Alabri, Rashid ;

Albu, Silviu ;

Alhabash, Saied .

RHINOLOGY, 2020, 58 :1-464

[6] Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps [J].

Gevaert, Philippe ;

Lang-Loidolt, Doris ;

Lackner, Andreas ;

Stammberger, Heinz ;

Staudinger, Heribert ;

Van Zele, Thibaut ;

Holtappels, Gabriele ;

Tavernier, Jan ;

van Cauwenberge, Paul ;

Bachert, Claus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (05) :1133-1141

[7] Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials [J].

Gevaert, Philippe ;

Omachi, Theodore A. ;

Corren, Jonathan ;

Mullol, Joaquim ;

Han, Joseph ;

Lee, Stella E. ;

Kaufman, Derrick ;

Ligueros-Saylan, Monica ;

Howard, Monet ;

Zhu, Rui ;

Owen, Ryan ;

Wong, Kit ;

Islam, Lutaf ;

Bachert, Claus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (03) :595-605

[8] Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma [J].

Gevaert, Philippe ;

Calus, Lien ;

Van Zele, Thibaut ;

Blomme, Katrien ;

De Ruyck, Natalie ;

Bauters, Wouter ;

Hellings, Peter ;

Brusselle, Guy ;

De Bacquer, Dirk ;

van Cauwenberge, Paul ;

Bachert, Claus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (01) :110-U166

[9] Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis [J].

Gevaert, Philippe ;

Van Bruaene, Nicholas ;

Cattaert, Tom ;

Van Steen, Kristel ;

Van Zele, Thibaut ;

Acke, Frederic ;

De Ruyck, Natalie ;

Blomme, Katrien ;

Sousa, Ana R. ;

Marshall, Richard P. ;

Bachert, Claus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (05) :989-U428

[10] Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Han, Joseph K. ;

Bachert, Claus ;

Fokkens, Wytske ;

Desrosiers, Martin ;

Wagenmann, Martin ;

Lee, Stella E. ;

Smith, Steven G. ;

Martin, Neil ;

Mayer, Bhabita ;

Yancey, Steven W. ;

Sousa, Ana R. ;

Chan, Robert ;

Hopkins, Claire .

LANCET RESPIRATORY MEDICINE, 2021, 9 (10) :1141-1153

← 1 2 →